Peptides & Peptide Synthesis Products

Fmoc-D-Phe-OH

Fmoc-D-Phe-OH
$10.00
$10.00
Fmoc-D-Phe-OH, Catalog No: 42012
Nα-Fmoc-D-phenylalanine, CAS: 86123-10-6, MW: 387.43, Formula: C24H21NO4
Catalog No: 42012
Nα-Fmoc-D-phenylalanine, CAS: 86123-10-6, MW: 387.43, Formula: C24H21NO4
Description

Details

Nα-Fmoc-D-phenylalanine
Additional Information

Additional Information

Catalog Number 42012
CAS 86123-10-6
M.W. 387.43
Formula C24H21NO4
IUPAC Name (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoic acid
Synonym Nα-Fmoc-D-phenylalanine
Also Known As
  • (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoic acid
  • (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenyl-propanoic acid
  • (2R)-2-[(9H-fluoren-9-ylmethoxy-oxomethyl)amino]-3-phenylpropanoic acid
  • (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenyl-propionic acid
  • 47378_FLUKA
  • Fmoc-D-Phe-OH
  • Fmoc-D-phenylalanine
InChIKey SJVFAHZPLIXNDH-JOCHJYFZSA-N
InChI InChI=1S/C24H21NO4/c26-23(27)22(14-16-8-2-1-3-9-16)25-24(28)29-15-21-19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h1-13,21-22H,14-15H2,(H,25,28)(H,26,27)/t22-/m1/s1
SMILES C1=CC=C(C=C1)C[C@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
Cited Uses

Details

1. Chen X et al, "Retro-Inverso Carbohydrate Mimetic Peptides with Annexin1-Binding Selectivity, Are Stable In Vivo, and Target Tumor Vasculature", PLoS ONE, 8(12) pp.e80390 ().
2. et al, "", , () pp. ().
3. G├╝ell I et al, "Multivalent display of the antimicrobial peptides BP100 and BP143", Beilstein Journal of Organic Chemistry, 8() pp.2106-2117 ().
4. Davis MR et al, "Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds", Tetrahedron, 68(4) pp.1029-1051 (2012 Jan 28).
5. Cheng C et al, "Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line", EJNMMI Research, 1() pp.34 ().
6. Wiessler M et al, "Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy", Theranostics, 1() pp.381-394 ().
7. Brabez N et al, "Design, synthesis and biological studies of efficient multivalent melanotropin ligands: tools towards melanoma diagnosis and treatment", Journal of medicinal chemistry, 54(20) pp.7375-7384 (2011 Oct 27).
8. Sellers RP et al, "Design and synthesis of Hsp90 Inhibitors: exploring the SAR of Sansalvamide A derivatives", Bioorganic & medicinal chemistry, 18(18) pp.6822-6856 (2010 Sep 15).
9. Ying J et al, "Design, Synthesis, and Biological Evaluation of New Cyclic Melanotropin Peptide Analogues Selective for the Human Melanocortin-4 Receptor", Journal of medicinal chemistry, 49(23) pp.6888-6896 (2006 Nov 16).
10. Agnes RS et al, "Structure-Activity Relationships of Bifunctional Peptides Based on Overlapping Pharmacophores at Opioid and Cholecystokinin Receptors", Journal of medicinal chemistry, 49(10) pp.2868-2875 (2006 May 18).
11. Bunin BA et al, "The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library.", Proceedings of the National Academy of Sciences of the United States of America, 91(11) pp.4708-4712 (1994 May 24).
12. Ahmed AR et al, "Isolation and partial purification of a melanocyte-stimulating hormone receptor from B16 murine melanoma cells. A novel approach using a cleavable biotinylated photoactivated ligand and streptavidin-coated magnetic beads.", Biochemical Journal, 286(Pt 2) pp.377-382 (1992 Sep 1).
Reviews
cr